Safety and Immunogenicity Study of Adenovirus-vectored, Intranasal Pandemic Influenza Vaccine.

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Vaxin Inc.
ClinicalTrials.gov Identifier:
NCT00755703
First received: September 17, 2008
Last updated: September 11, 2012
Last verified: September 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2011
  Primary Completion Date: September 2009 (Final data collection date for primary outcome measure)